Truglyx 4 mg Pen 3 ml
Rs. 3,315.50
Title
Truglyx 4 mg Pen 3 ml
Prescription drug
Expiry
:
31-10-2027
AboutTruglyx 4 mg Pen is a prefilled injectable medicine for type 2 diabetes. The exact active ingredient, dosing schedule, and storage requirement must be verified from the product carton before listing.Usage InstructionsUse only as prescribed and trained by a healthcare professional. Inject subcutaneously according to the approved dosing schedule; do not share pens or needles.BenefitsMay help improve blood glucose control in adults with type 2 diabetes when used with diet and exercise.How it WorksThe mechanism depends on the verified active ingredient; many injectable diabetes therapies enhance insulin action or reduce glucose release after meals.Side EffectsNausea, vomiting, diarrhoea, reduced appetite, low blood sugar when used with insulin or sulfonylureas, and injection-site reactions may occur depending on the formulation.Safety AdvicePrescription use only; verify product-specific contraindications; monitor blood glucose; seek urgent care for severe abdominal pain, allergic reaction, or persistent vomiting.StorageVerify carton instructions before publication. Most prefilled diabetes pens require refrigerated storage at 2°C to 8°C before first use and must not be frozen.
₹3,315.50
MRP: ₹3,490.00
Save ₹174.50
(5%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
AboutTruglyx 4 mg Pen is a prefilled injectable medicine for type 2 diabetes. The exact active ingredient, dosing schedule, and storage requirement must be verified from the product carton before listing.Usage InstructionsUse only as prescribed and trained by a healthcare professional. Inject subcutaneously according to the approved dosing schedule; do not share pens or needles.BenefitsMay help improve blood glucose control in adults with type 2 diabetes when used with diet and exercise.How it WorksThe mechanism depends on the verified active ingredient; many injectable diabetes therapies enhance insulin action or reduce glucose release after meals.Side EffectsNausea, vomiting, diarrhoea, reduced appetite, low blood sugar when used with insulin or sulfonylureas, and injection-site reactions may occur depending on the formulation.Safety AdvicePrescription use only; verify product-specific contraindications; monitor blood glucose; seek urgent care for severe abdominal pain, allergic reaction, or persistent vomiting.StorageVerify carton instructions before publication. Most prefilled diabetes pens require refrigerated storage at 2°C to 8°C before first use and must not be frozen.